Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREWENT Study of intermittent Neoral for relapse prevention in chronic plaque psoriasis in remission
2006-000207-42Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in plaque psoriasis comparing Neoral intermittent maintenance with Placebo (2 arms). Primary endpoint: Relapse rate. Started Apr 2006; status: completed.
02
Drugs
cyclosporine
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2006-000207-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000207-42.